711 related articles for article (PubMed ID: 34533570)
1. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC
JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570
[TBL] [Abstract][Full Text] [Related]
2. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
[TBL] [Abstract][Full Text] [Related]
3. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
[TBL] [Abstract][Full Text] [Related]
4. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
[TBL] [Abstract][Full Text] [Related]
5. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
6. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
[TBL] [Abstract][Full Text] [Related]
7. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S
Vaccine; 2023 Jun; 41(28):4183-4189. PubMed ID: 37244808
[TBL] [Abstract][Full Text] [Related]
9. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
[TBL] [Abstract][Full Text] [Related]
11. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
[TBL] [Abstract][Full Text] [Related]
12. Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
ALMuhizi F; Fein M; Gabrielli S; Gilbert L; Tsoukas C; Ben-Shoshan M; Copaescu AM; Isabwe GAC
Ann Allergy Asthma Immunol; 2022 Aug; 129(2):182-188.e1. PubMed ID: 35609744
[TBL] [Abstract][Full Text] [Related]
13. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
[TBL] [Abstract][Full Text] [Related]
14. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
[TBL] [Abstract][Full Text] [Related]
15. Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions.
Vespa S; Del Biondo P; Simeone P; Cavallucci E; Catitti G; Auciello R; De Bellis D; Altomare I; Pierdomenico L; Canonico B; Cicalini I; Angilletta I; Del Boccio P; Pieragostino D; Santilli F; Urbani A; De Laurenzi V; Stuppia L; Lanuti P
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498922
[TBL] [Abstract][Full Text] [Related]
16. Allergy to COVID-19 vaccines: A current update.
Cabanillas B; Novak N
Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
[TBL] [Abstract][Full Text] [Related]
17. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.
Labella M; Céspedes JA; Doña I; Shamji MH; Agache I; Mayorga C; Torres MJ
Allergy; 2022 Jul; 77(7):2067-2079. PubMed ID: 34689351
[TBL] [Abstract][Full Text] [Related]
18. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.
Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jošt M; Caubet JC; Carmo A; Mona AA; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-López N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Doña I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gülen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Kepil Özdemir S; Klimek L; Košnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu FD; Porebski G; Radice A; Regateiro FS; Röckmann H; Romano A; Sargur R; Sastre J; Scherer Hofmeier K; Sedláčková L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wöhrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
Allergy; 2022 Aug; 77(8):2292-2312. PubMed ID: 35112371
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
20. Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates.
Kogseder N; Puxkandl V; Hoetzenecker W; Altrichter S
Front Immunol; 2024; 15():1324987. PubMed ID: 38827735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
